Cerevel Therapeutics Holdings | 4:持股变动声明-董事 COLES N ANTHONY
Cerevel Therapeutics Holdings | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(0.287%),Abigail P. Johnson(0.287%)
Cerevel Therapeutics Holdings | 4:持股变动声明-董事 COLES N ANTHONY
Cerevel Therapeutics Holdings | 4:持股变动声明-董事 COLES N ANTHONY
Cerevel Therapeutics Holdings | 4:持股变动声明-董事 COLES N ANTHONY
Cerevel Therapeutics Holdings | 4:持股变动声明-董事 PERCEPTIVE ADVISORS LLC
Cerevel Therapeutics Holdings | 5:权益变更年度报表-董事 Sulzberger Gabrielle
Cerevel Therapeutics Holdings | 4:持股变动声明-高管 Renger John
Cerevel Therapeutics Holdings | 4:持股变动声明-董事 COLES N ANTHONY
Cerevel Therapeutics Holdings | 4:持股变动声明-高管 ALTSCHULLER Susan
Cerevel Therapeutics Holdings | 4:持股变动声明-高管 Renger John
Cerevel Therapeutics Holdings | 4:持股变动声明-高管 Tregoning Kathleen
Cerevel Therapeutics Holdings | 4:持股变动声明-高管 DiPietro Kenneth
Cerevel Therapeutics Holdings | 4:持股变动声明-高管 Bodenrader Mark
Cerevel Therapeutics Holdings | 4:持股变动声明-高管 Burgess Paul D.
Cerevel Therapeutics Holdings | 4:持股变动声明-高管 Sanchez Ramiro
Cerevel Therapeutics Holdings | 4:持股变动声明-高管 Renaud Ronald C JR
Cerevel Therapeutics Holdings | 4:持股变动声明-高管 Akamine Scott
Cerevel Therapeutics Holdings | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(5.365%),Abigail P. Johnson(5.365%)
Cerevel Therapeutics Holdings | 4:持股变动声明-董事 COLES N ANTHONY
暂无数据